S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
Log in
NYSE:MRM

Medirom Healthcare Technologies Stock Forecast, Price & News

$13.76
-1.60 (-10.42 %)
(As of 01/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$13.62
Now: $13.76
$15.56
50-Day Range N/A
52-Week Range
$12.70
Now: $13.76
$19.80
Volume96,504 shs
Average Volume198,143 shs
Market Capitalization$66.36 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MEDIROM Healthcare Technologies Inc. provides holistic health services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment operates and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. As of June 30, 2020, this segment had a total of 289 salons consisting of 138 directly operated salons and 151 franchised salons primarily in the Tokyo metropolitan area, which includes Tokyo, Yokohama, and Saitama. The Digital Preventative Healthcare segment engages in the sampling business, which includes brand promotion and consumer analysis for third party brands of corporate clients. This segment also offers government-sponsored Specific Health Guidance program, utilizing its internally-developed on-demand health monitoring smartphone application, Lav; MOTHER Tracker for fitness applications; and preventative healthcare services utilizing its digital application and devices. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques located in the Odaiba area in Tokyo. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was founded in 2000 and is headquartered in Tokyo, Japan.

MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1896th out of 1,926 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone81 3 6721 7364
Employees180

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$66.36 million
Next Earnings DateN/A
OptionableNot Optionable
$13.76
-1.60 (-10.42 %)
(As of 01/21/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MRM News and Ratings via Email

Sign-up to receive the latest news and ratings for MRM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Medirom Healthcare Technologies (NYSE:MRM) Frequently Asked Questions

What stocks does MarketBeat like better than Medirom Healthcare Technologies?

Wall Street analysts have given Medirom Healthcare Technologies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Medirom Healthcare Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Larry J. Merlo's approval rating as Medirom Healthcare Technologies' CEO?

6,978 employees have rated Medirom Healthcare Technologies CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among Medirom Healthcare Technologies' employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Medirom Healthcare Technologies' key competitors?

When did Medirom Healthcare Technologies IPO?

(MRM) raised $12 million in an initial public offering (IPO) on Tuesday, December 29th 2020. The company issued 800,000 shares at a price of $15.00 per share. Maxim Group LLC acted as the underwriter for the IPO.

What is Medirom Healthcare Technologies' stock symbol?

Medirom Healthcare Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRM."

When does Medirom Healthcare Technologies' quiet period expire?

Medirom Healthcare Technologies' quiet period expires on Monday, February 8th. Medirom Healthcare Technologies had issued 800,000 shares in its initial public offering on December 29th. The total size of the offering was $12,000,000 based on an initial share price of $15.00. During Medirom Healthcare Technologies' quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Medirom Healthcare Technologies?

Shares of MRM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Medirom Healthcare Technologies' stock price today?

One share of MRM stock can currently be purchased for approximately $13.76.

How big of a company is Medirom Healthcare Technologies?

Medirom Healthcare Technologies has a market capitalization of $66.36 million. Medirom Healthcare Technologies employs 180 workers across the globe.

What is Medirom Healthcare Technologies' official website?

The official website for Medirom Healthcare Technologies is medirom.co.jp.

How can I contact Medirom Healthcare Technologies?

The company can be reached via phone at 81 3 6721 7364.

This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.